Total submissions: 1
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Labcorp Genetics |
RCV001993342 | SCV002230790 | pathogenic | not provided | 2021-09-14 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg316*) in the EIF2B5 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in EIF2B5 are known to be pathogenic (PMID: 11704758, 15060152, 21307862). This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals affected with EIF2B5-related conditions. For these reasons, this variant has been classified as Pathogenic. |